Correlation Between 23Andme Holding and Hookipa Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Hookipa Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Hookipa Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Hookipa Pharma, you can compare the effects of market volatilities on 23Andme Holding and Hookipa Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Hookipa Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Hookipa Pharma.

Diversification Opportunities for 23Andme Holding and Hookipa Pharma

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between 23Andme and Hookipa is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Hookipa Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hookipa Pharma and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Hookipa Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hookipa Pharma has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Hookipa Pharma go up and down completely randomly.

Pair Corralation between 23Andme Holding and Hookipa Pharma

Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to generate 1.71 times more return on investment than Hookipa Pharma. However, 23Andme Holding is 1.71 times more volatile than Hookipa Pharma. It trades about -0.12 of its potential returns per unit of risk. Hookipa Pharma is currently generating about -0.27 per unit of risk. If you would invest  602.00  in 23Andme Holding Co on August 31, 2024 and sell it today you would lose (288.00) from holding 23Andme Holding Co or give up 47.84% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

23Andme Holding Co  vs.  Hookipa Pharma

 Performance 
       Timeline  
23Andme Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 23Andme Holding Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Hookipa Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hookipa Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

23Andme Holding and Hookipa Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 23Andme Holding and Hookipa Pharma

The main advantage of trading using opposite 23Andme Holding and Hookipa Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Hookipa Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hookipa Pharma will offset losses from the drop in Hookipa Pharma's long position.
The idea behind 23Andme Holding Co and Hookipa Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Fundamental Analysis
View fundamental data based on most recent published financial statements
Insider Screener
Find insiders across different sectors to evaluate their impact on performance